Allogeneic hematopoietic stem cell transplantation in the COVID-19 era

Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) recipients are especially vulnerable to coronavirus disease 19 (COVID-19), because of their profound immunodeficiency. Indeed, the first pandemic wave was marked by a high mortality rate in this population. Factors increasing immunodepre...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordat, Jonathan, Maury, Sébastien, Leclerc, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993088/
https://www.ncbi.nlm.nih.gov/pubmed/36911678
http://dx.doi.org/10.3389/fimmu.2023.1100468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993088/
https://www.ncbi.nlm.nih.gov/pubmed/36911678
http://dx.doi.org/10.3389/fimmu.2023.1100468

Ejemplares similares